Index S&P 500
P/E 38.05
EPS (ttm) 15.59
Insider Own 0.19%
Shs Outstand 386.65M
Perf Week 3.61%
Market Cap 226.37B
Forward P/E 24.32
EPS next Y 24.39
Insider Trans -15.85%
Shs Float 380.98M
Perf Month 3.21%
Income 6.03B
PEG 5.74
EPS next Q 5.12
Inst Own 92.30%
Short Float 0.73%
Perf Quarter 7.68%
Sales 42.49B
P/S 5.33
EPS this Y 0.69%
Inst Trans 0.05%
Short Ratio 2.04
Perf Half Y 30.53%
Book/sh 119.24
P/B 4.97
EPS next Y 12.39%
ROA 6.29%
Short Interest 2.77M
Perf Year 11.16%
Cash/sh 19.01
P/C 31.19
EPS next 5Y 6.63%
ROE 13.75%
52W Range 415.60 - 603.82
Perf YTD 11.73%
Dividend Est. 1.50 (0.25%)
P/FCF 29.94
EPS past 5Y 16.37%
ROI 7.87%
52W High -1.79%
Beta 0.80
Dividend TTM 1.44 (0.24%)
Quick Ratio 1.33
Sales past 5Y 12.53%
Gross Margin 39.47%
52W Low 42.69%
ATR (14) 11.03
Dividend Ex-Date Mar 14, 2024
Current Ratio 1.70
EPS Y/Y TTM 1.48%
Oper. Margin 17.58%
RSI (14) 64.62
Volatility 1.63% 1.95%
Employees 122000
Debt/Eq 0.78
Sales Y/Y TTM -3.00%
Profit Margin 14.20%
Recom 1.75
Target Price 625.46
Option/Short Yes / Yes
LT Debt/Eq 0.68
EPS Q/Q 4.10%
Payout 9.06%
Rel Volume 0.98
Prev Close 577.93
Sales Surprise 1.87%
EPS Surprise 8.52%
Sales Q/Q -3.41%
Earnings Apr 24 BMO
Avg Volume 1.35M
Price 593.03
SMA20 4.78%
SMA50 3.02%
SMA200 11.59%
Trades
Volume 1,328,783
Change 2.61%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-18-24 Resumed
Citigroup
Neutral
$620
Jan-24-24 Downgrade
Barclays
Overweight → Equal Weight
$475 → $555
Jan-08-24 Downgrade
Bernstein
Outperform → Mkt Perform
Dec-18-23 Initiated
HSBC Securities
Buy
$610
Dec-13-23 Initiated
Wolfe Research
Outperform
$575
Oct-26-23 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Oct-25-23 Upgrade
Wells Fargo
Underweight → Equal Weight
$52 → $475
Sep-28-23 Initiated
Bernstein
Outperform
$603
Sep-06-23 Resumed
Citigroup
Buy
$625
Jul-19-23 Reiterated
Robert W. Baird
Outperform
$670 → $664
Jul-19-23 Initiated
Raymond James
Outperform
$595
Jul-13-23 Upgrade
Credit Suisse
Neutral → Outperform
$620
Apr-04-23 Reiterated
Barclays
Overweight
$660 → $625
Dec-14-22 Initiated
Deutsche Bank
Buy
$620
Dec-07-22 Initiated
RBC Capital Mkts
Outperform
$661
Oct-27-22 Downgrade
The Benchmark Company
Buy → Hold
Aug-25-22 Initiated
Credit Suisse
Neutral
$675
Apr-25-22 Downgrade
Wells Fargo
Equal Weight → Underweight
$525
Jan-26-22 Resumed
Barclays
Overweight
$700
Oct-20-21 Upgrade
Citigroup
Neutral → Buy
$620 → $700
Show Previous Ratings
May-10-24 08:15AM
07:10AM
May-09-24 03:45PM
May-07-24 12:45PM
08:00AM
07:45AM
Loading…
07:45AM
May-06-24 08:48AM
May-04-24 01:02AM
May-03-24 04:21AM
May-02-24 04:49PM
May-01-24 11:24AM
10:58AM
08:00AM
Apr-29-24 04:46PM
02:35PM
10:38AM
Loading…
10:38AM
06:45AM
Apr-26-24 08:17AM
Apr-25-24 12:50PM
03:03AM
Apr-24-24 10:41PM
(Thomson Reuters StreetEvents)
02:15PM
02:15PM
12:38PM
11:54AM
11:17AM
11:03AM
10:54AM
09:30AM
07:31AM
07:11AM
Loading…
07:11AM
06:46AM
06:06AM
(Associated Press Finance)
06:05AM
06:00AM
04:01AM
Apr-23-24 06:59AM
Apr-22-24 11:09AM
Apr-21-24 07:00AM
Apr-20-24 09:16AM
Apr-19-24 09:15AM
07:53AM
Apr-18-24 04:27PM
Apr-16-24 08:00AM
Apr-15-24 12:58PM
Apr-13-24 10:02AM
Apr-10-24 01:22PM
Apr-09-24 08:34AM
Apr-05-24 06:00PM
Apr-04-24 09:00AM
Apr-02-24 06:15PM
08:36AM
08:00AM
08:00AM
Mar-28-24 02:36PM
02:10PM
02:07PM
08:01AM
Mar-27-24 06:00PM
Mar-26-24 06:15PM
08:02AM
Mar-22-24 09:41AM
Mar-21-24 10:25AM
02:53AM
Mar-20-24 06:00PM
06:29AM
Mar-19-24 08:00AM
Mar-18-24 06:15PM
Mar-17-24 05:47PM
Mar-14-24 12:00PM
09:38AM
09:00AM
Mar-12-24 06:00PM
09:09AM
Mar-11-24 03:04PM
10:20AM
Mar-06-24 06:00PM
02:45PM
(Investor's Business Daily)
Mar-05-24 06:00AM
Mar-01-24 11:30AM
09:00AM
08:00AM
Feb-29-24 09:30PM
06:00PM
03:04PM
Feb-28-24 08:00AM
Feb-26-24 01:19PM
Feb-23-24 12:02AM
Feb-21-24 05:00PM
Feb-20-24 06:00AM
Feb-19-24 10:55AM
Feb-17-24 01:29PM
Feb-15-24 04:13PM
06:11AM
Feb-14-24 10:01AM
Feb-13-24 02:41PM
Feb-10-24 10:25AM
Feb-06-24 08:43AM
08:12AM
06:01AM
Thermo Fisher Scientific, Inc. engages in the provision of analytical instruments, equipment, reagents and consumables, software, and services for research, analysis, discovery, and diagnostics. It operates through the following segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. The Life Sciences Solutions segment is composed of a portfolio of reagents, instruments, and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of infection and disease. The Analytical Instruments segment offers instruments, consumables, software, and services that are used for a range of applications in the laboratory, on the production line, and in the field. The Specialty Diagnostics segment provides diagnostic test kits, reagents, culture media, instruments, and associated products used to increase the speed and accuracy of diagnoses. The Laboratory Products and Services segment is involved in providing everything needed for the laboratory, including a combination of self-manufactured and sourced products for customers in research, academic, government, industrial, and healthcare settings. The company was founded on October 11, 1960 and is headquartered in Waltham, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
CASPER MARC N Chairman & CEO May 01 '24 Option Exercise 190.59 10,000 1,905,900 133,816 May 02 04:19 PM CASPER MARC N Chairman & CEO May 01 '24 Sale 573.74 10,000 5,737,356 123,816 May 02 04:19 PM CASPER MARC N Chairman & CEO Apr 30 '24 Option Exercise 190.59 10,000 1,905,900 133,816 May 01 04:35 PM CASPER MARC N Chairman & CEO Apr 30 '24 Sale 572.41 10,000 5,724,147 123,816 May 01 04:35 PM CASPER MARC N Chairman & CEO Apr 29 '24 Option Exercise 190.59 10,000 1,905,900 133,816 May 01 04:35 PM CASPER MARC N Chairman & CEO Apr 29 '24 Sale 575.94 10,000 5,759,384 123,816 May 01 04:35 PM Boxer Michael A SVP and General Counsel Apr 26 '24 Option Exercise 210.68 2,000 421,360 15,083 Apr 29 04:43 PM Boxer Michael A SVP and General Counsel Apr 26 '24 Sale 567.94 2,000 1,135,880 13,083 Apr 29 04:43 PM CASPER MARC N Chairman & CEO Mar 13 '24 Option Exercise 190.59 10,000 1,905,900 133,816 Mar 14 04:03 PM CASPER MARC N Chairman & CEO Mar 13 '24 Sale 594.58 10,000 5,945,759 123,816 Mar 14 04:03 PM Britt Lisa P. Sr. VP and Chief HR Officer Mar 12 '24 Option Exercise 198.85 14,345 2,852,545 25,768 Mar 13 04:31 PM CASPER MARC N Chairman & CEO Mar 12 '24 Option Exercise 190.59 10,000 1,905,900 133,816 Mar 13 05:24 PM Britt Lisa P. Sr. VP and Chief HR Officer Mar 12 '24 Sale 598.90 14,345 8,591,220 17,323 Mar 13 04:31 PM CASPER MARC N Chairman & CEO Mar 12 '24 Sale 597.98 10,000 5,979,758 123,816 Mar 13 05:24 PM CASPER MARC N Chairman & CEO Mar 11 '24 Option Exercise 190.59 10,000 1,905,900 135,816 Mar 13 05:24 PM CASPER MARC N Chairman & CEO Mar 11 '24 Sale 595.36 10,000 5,953,598 125,816 Mar 13 05:24 PM CASPER MARC N Chairman & CEO Feb 29 '24 Option Exercise 190.59 10,000 1,905,900 135,816 Mar 04 04:36 PM CASPER MARC N Chairman & CEO Feb 29 '24 Sale 571.08 10,000 5,710,818 125,816 Mar 04 04:36 PM CASPER MARC N Chairman & CEO Feb 28 '24 Option Exercise 190.59 10,000 1,905,900 138,485 Feb 29 04:56 PM CASPER MARC N Chairman & CEO Feb 28 '24 Sale 570.18 10,000 5,701,759 128,485 Feb 29 04:56 PM CASPER MARC N Chairman & CEO Feb 27 '24 Option Exercise 190.59 10,000 1,905,900 138,485 Feb 29 04:56 PM CASPER MARC N Chairman & CEO Feb 27 '24 Sale 564.72 10,000 5,647,196 128,485 Feb 29 04:56 PM CASPER MARC N Chairman & CEO Feb 15 '24 Sale 550.62 5,547 3,054,290 43,608 Feb 20 04:51 PM Spar Debora L Director Feb 12 '24 Sale 546.97 164 89,703 1,207 Feb 14 04:36 PM Boxer Michael A SVP and General Counsel Feb 07 '24 Option Exercise 192.98 14,566 2,810,947 27,467 Feb 08 04:53 PM Boxer Michael A SVP and General Counsel Feb 07 '24 Sale 562.00 14,566 8,186,092 12,901 Feb 08 04:53 PM CASPER MARC N Chairman & CEO Feb 07 '24 Sale 555.63 10,000 5,556,287 49,155 Feb 08 04:51 PM CASPER MARC N Chairman & CEO Nov 07 '23 Option Exercise 157.68 1,600 252,288 132,775 Nov 08 04:09 PM CASPER MARC N Chairman & CEO Nov 07 '23 Sale 460.25 1,600 736,404 131,175 Nov 08 04:09 PM CASPER MARC N Chairman & CEO Nov 06 '23 Option Exercise 157.68 10,000 1,576,800 141,175 Nov 08 04:09 PM CASPER MARC N Chairman & CEO Nov 06 '23 Sale 454.41 10,000 4,544,053 131,175 Nov 08 04:09 PM CASPER MARC N Chairman & CEO Nov 03 '23 Option Exercise 157.68 10,000 1,576,800 141,175 Nov 06 04:34 PM CASPER MARC N Chairman & CEO Nov 03 '23 Sale 456.15 10,000 4,561,459 131,175 Nov 06 04:34 PM CASPER MARC N Chairman & CEO Nov 02 '23 Option Exercise 157.68 10,000 1,576,800 141,175 Nov 06 04:34 PM CASPER MARC N Chairman & CEO Nov 02 '23 Sale 445.49 10,000 4,454,880 131,175 Nov 06 04:34 PM Pettiti Gianluca Executive Vice President Aug 30 '23 Option Exercise 253.99 3,000 761,970 20,556 Aug 31 04:15 PM Pettiti Gianluca Executive Vice President Aug 30 '23 Sale 557.77 3,000 1,673,310 17,556 Aug 31 04:15 PM CASPER MARC N Chairman & CEO Aug 08 '23 Option Exercise 157.68 1,600 252,288 136,930 Aug 09 04:01 PM CASPER MARC N Chairman & CEO Aug 08 '23 Sale 550.60 1,600 880,960 135,330 Aug 09 04:01 PM CASPER MARC N Chairman & CEO Aug 07 '23 Option Exercise 157.68 10,000 1,576,800 145,330 Aug 09 04:01 PM CASPER MARC N Chairman & CEO Aug 07 '23 Sale 551.94 10,000 5,519,370 135,330 Aug 09 04:01 PM CASPER MARC N Chairman & CEO Aug 04 '23 Option Exercise 157.68 10,000 1,576,800 145,330 Aug 07 04:05 PM CASPER MARC N Chairman & CEO Aug 04 '23 Sale 550.33 10,000 5,503,317 135,330 Aug 07 04:05 PM CASPER MARC N Chairman & CEO Aug 03 '23 Option Exercise 157.68 10,000 1,576,800 151,330 Aug 07 04:05 PM CASPER MARC N Chairman & CEO Aug 03 '23 Sale 549.00 10,000 5,490,050 141,330 Aug 07 04:05 PM Williamson Stephen Sr. VP and CFO Aug 01 '23 Option Exercise 190.59 14,100 2,687,319 41,493 Aug 02 04:33 PM Williamson Stephen Sr. VP and CFO Aug 01 '23 Sale 550.00 14,100 7,755,000 27,393 Aug 02 04:33 PM Williamson Stephen Sr. VP and CFO Jul 31 '23 Option Exercise 190.59 15,000 2,858,850 42,393 Aug 02 04:33 PM Williamson Stephen Sr. VP and CFO Jul 31 '23 Sale 557.42 15,000 8,361,300 27,393 Aug 02 04:33 PM Boxer Michael A SVP and General Counsel Jun 26 '23 Buy 526.15 4 2,105 13,101 Oct 06 04:23 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite